[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100460553":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":33,"collaborators":10,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":10,"eligibilityCriteria":42,"healthyVolunteers":39,"sex":43,"minAge":44,"maxAge":10,"enrollmentInfo":45,"targetDuration":10,"studyType":48,"phases":10,"briefSummary":49,"conditions":50,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"University of Oslo","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Stroke patients",null,[12],"Other: Analysis of post-stroke immune responses",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"Analysis of post-stroke immune responses","Analysis of immune responses in peripheral blood",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Andreas Lossius, MD, PhD","CONTACT","+47 930 68 515","postmottak@medisin.uio.no",[25],{"facility":26,"status":27,"city":28,"state":10,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":10,"geoPoint":10,"contacts":31},"Akershus University Hospital","RECRUITING","Lørenskog","Norway","NO",[32],{"name":20,"role":21,"phone":10,"phoneExt":10,"email":10},{"type":34,"investigatorFullName":35,"investigatorTitle":36,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Andreas Lossius","Associate Professor","100460553","the-immune-response-to-stroke-100460553",false,"NCT05277129","The Immune Response to Stroke","Inclusion Criteria:\n\n* Stroke \\\u003C 72 h\n* Age \\> 18 years\n\nExclusion Criteria:\n\n* Brain hemorrhage verified by CT or MRI scan\n* Previous or present immunological disease or other serious comorbidity\n* Ongoing immune respons after infection or vaccination \\\u003C 1 month\n* Cognitive without ability to understand and\u002For give an informed consent to participate in the study","ALL","18 Years",{"count":46,"type":47},40,"ESTIMATED","OBSERVATIONAL","Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.",[51,52],"Stroke, Acute","Dementia","2022-03-03",{"date":55,"type":56},"2022-03-14","ACTUAL",{"date":58,"type":56},"2021-06-24",{"date":60,"type":47},"2029-06-06",{"name":5,"class":6},1]